SynthesisClinical drug investigation2024

Systematic Review with Meta-analysis: Efficacy and Safety of Upadacitinib in Managing Moderate-to-Severe Crohn's Disease and Ulcerative Colitis.

Chengu Niu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.